AstraZeneca to deliver Covid-19 antibody therapy doses to Switzerland
The tixagevimab and cilgavimab combination is anticipated to be made available in August.
Switzerland
Latest in
Switzerland
Genentech expands immuno-oncology partnership with Bicycle Therapeutics
The companies are working on discovering and conducting pre-clinical development of new immunotherapies for various targets.
Kinarus’ therapy offers robust antiviral activity against Covid-19 variants
KIN001 acts on the host cell pathways required for the replication of the virus.
Pierre Fabre and Lonza sign antibody manufacturing agreement
W0180 is presently being analysed in a Phase I clinical trial for various solid tumours.
WHO grants EUL to CanSinoBIO’s Covid-19 vaccine
The decision is based on the totality of scientific data, including findings from a Phase III trial of Convidecia.
Roche reports 11% rise in group sales for Q1 2022
The rise in sales in the Pharmaceuticals Division for Q1 2022 was attributed to sales of new therapies for severe…
WHO recommends use of Pfizer’s oral Covid-19 drug
The latest advice is based on recent findings from two randomised, controlled trials that enrolled 3078 patients.
WHO grants EUL for Johnson & Johnson Covid-19 booster vaccine
As per the updated EUL, the Covid-19 vaccine could be used for homologous and heterologous boosting.